SLU-PP-332
SLU-PP-332 is a synthetic peptide developed for advanced research in metabolic and endocrine signaling pathways. It is designed to act as a long-acting analog with selective receptor activity, enabling controlled studies of energy regulation, appetite signaling, and hormone-mediated cellular processes.
In laboratory research, SLU-PP-332 is valued for its ability to modulate peptide-receptor interactions associated with metabolic homeostasis. Its structural design allows for prolonged signaling effects, making it a useful tool for studying sustained receptor engagement in experimental models.
One of the defining characteristics of SLU-PP-332 is its receptor specificity. By targeting select pathways, researchers can examine downstream signaling effects without interference from unrelated systems, allowing for precise mechanistic studies.
SLU-PP-332 is frequently included in studies investigating appetite and satiety-related signaling. It enables scientists to explore how peptide-mediated receptor activation influences complex neuroendocrine networks responsible for energy balance.
The peptide is also studied for its effects on cellular metabolic pathways. Researchers examine how SLU-PP-332 impacts intracellular signaling cascades, nutrient utilization, and downstream transcriptional activity in controlled laboratory settings.
Its enhanced stability and prolonged activity profile make SLU-PP-332 particularly suitable for research that requires consistent and predictable peptide behavior. This reliability is essential for reproducible results and comparative studies.
Researchers also investigate SLU-PP-332 in combination with other peptides and hormonal modulators to evaluate synergistic effects on metabolic regulation and receptor signaling dynamics.
Unlike general receptor agonists, SLU-PP-332 is designed for selective and targeted activity. This precision allows for detailed investigation of specific pathways without broad systemic activation.
SLU-PP-332 is often included in systems-based research, where multiple interrelated pathways are studied together to understand complex physiological responses at the cellular and molecular levels.
The peptide’s compact and well-characterized structure supports reproducibility in laboratory experiments and facilitates precise analysis of structure–function relationships in receptor biology.
SLU-PP-332 continues to be of interest in advanced metabolic research due to its combination of stability, specificity, and relevance to peptide-mediated signaling science.
As peptide-based research expands, SLU-PP-332 remains a key compound for investigating the molecular mechanisms underlying appetite regulation, energy homeostasis, and receptor-mediated cellular communication.
Its unique design, prolonged activity, and receptor-targeted signaling make SLU-PP-332 an essential research tool for scientists studying complex endocrine and metabolic systems.
New
SLU-PP-332
$166.00
SLU-PP-332 is a synthetic peptide developed for advanced research in metabolic and endocrine signaling pathways. It is designed to act as a long-acting analog with selective receptor activity, enabling controlled studies of energy regulation, appetite signaling, and hormone-mediated cellular processes.
Description
Shipping & Delivery
Related products
BPC-157 5mg
BPC-157 has undergone a great deal of research because its healing abilities extend well beyond the lining of the stomach. Studies in animal models indicate that BPC-157 can enhance angiogenesis, promote wound healing, stimulate collagen synthesis, modulate the inflammatory response, and protect against oxidative stress. The peptide has shown benefits in animal models with inflammatory bowel disease, GI ulcers, musculoskeletal injuries, heart damage, eye injuries and neurological damage. Research has shown that the oral bioavailability of BPC-157 is quite high. 
BPC-157, TB-500 (Blend)
BPC-157 has undergone a great deal of research because its healing abilities extend well beyond the lining of the stomach. Studies in animal models indicate that BPC-157 can enhance angiogenesis, promote wound healing, stimulate collagen synthesis, modulate the inflammatory response, and protect against oxidative stress. The peptide has shown benefits in animal models with inflammatory bowel disease, GI ulcers, musculoskeletal injuries, heart damage, eye injuries and neurological damage. Research has shown that the oral bioavailability of BPC-157 is quite high. 
Dihexa (5mg x 60 Capsules = 300mg)
Dihexa is a small peptide-derived compound designed to support cognitive function and brain regeneration. It acts by activating the HGF/c-Met signaling pathway, which plays a critical role in forming new synaptic connections and enhancing neuroplasticity. Dihexa also mimics the action of brain-derived neurotrophic factor (BDNF), a key molecule involved in learning, memory, and neuronal survival. Preclinical research studies have shown that Dihexa can significantly improve memory consolidation and reverse cognitive deficits in models of Alzheimer’s disease, traumatic brain injury, and stroke. Unlike traditional nootropics or growth factors with poor blood–brain barrier penetration, Dihexa is orally bioavailable and metabolically stable, allowing for targeted CNS effects. Its unique mechanism positions it as a promising research compound for neurodegenerative conditions, offering potential in synaptic repair, inflammation reduction, and long-term cognitive enhancement. 
Epitalon 3mg (60 capsules) (Telomere Length)
Epithalon (Epitalon) has long been understood to help preserve telomeres, which are the protective end caps found on fragments of DNA (chromosomes). Telomeres protect DNA from degradation as it is replicated during cell division (one cell splitting into two). Telomeres themselves suffer degradation, however, and eventually become too short to be effective. At this point, a cell will either commit cell suicide in a process called apoptosis or it will go dormant in a process called senescence. Both processes lead to aging and eventual dysfunction and disease. Senescence is one of the primary drivers of disease and aging.
Epitalon has been shown to activate an enzyme called telomerase, which protects and repairs telomeres. More active telomerase means that cells age slower and remain functional longer. The net result is that overall aging appears to be slowed down. Research in rodents indicates that Epitalon may extend life by as much as 27% via this mechanism[2], [3].
Epitalon does not only activate telomerase. As noted above, Epitalon has been shown to affect expression for several genes through alteration of DNA structure. This process, called epigenetic modification, is of interest to scientists because it provides the foundation for controlling gene expression at a very fine level. Research is being conducted to learn how to harness epigenetic technology, which could potentially allow scientists to alter everything from an individual’s eye color to how intelligent a person is or how long someone lives.
Micro-encapsulated Epitalon has shown excellent orally bioavailability in lab research studies. 
TB-500 (Thymosin Beta-4) (43aa) (2mg x 10 Vials = 20mg)
TB-500 (Thymosin Beta-4) is a 43 amino acid peptide sequence. In animal models, Thymosin Beta-4 has been shown to improve blood vessel growth, regulate wound healing, decrease inflammation, and reduce oxidative damage in the heart and central nervous system. Thymosin-beta-4 has a role in protection, tissue repair, regeneration and remodeling of injured or damaged tissues. It is also of active interest in anti-aging research.
Reviews
There are no reviews yet.